Mereo BioPharma Group (MREO) Earnings Analysis
Mereo BioPharma Group (MREO) next reports earnings on 2026-08-11, consensus EPS -0.01 USD. Last quarter (2026-03-19) it beat with EPS -0.01 USD vs -0.01 USD est (0%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -1.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MREO next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.01 USD |
| Revenue estimate | 0.00B |
MREO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-19 | -0.01 USD | -0.01 USD | 0% | Beat |
| 2025-11-10 | -0.01 USD | -0.00833 USD | -20% | Miss |
| 2025-08-12 | -0.02 USD | -0.01 USD | -100% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
MREO valuation and analyst view
| Trailing P/E | -1.33 |
|---|---|
| Trailing EPS | -0.22261 USD |
| Price / book | 1.40 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Buy (5 buy / 3 hold / 0 sell) |
| Avg price target | 2.13 USD |
Related research pages
Frequently asked questions
When is Mereo BioPharma Group (MREO)'s next earnings date?
Mereo BioPharma Group is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.01 USD and revenue estimate of 0.00B.
Did MREO beat earnings last quarter?
In its 2026-03-19 report, MREO posted EPS of -0.01 USD versus a -0.01 USD estimate — a beat of 0%.
What is MREO's earnings track record?
Over the last 3 reported quarters with consensus data, MREO beat estimates 1 times (33%).
What is MREO's current P/E ratio and EPS?
MREO trades at a trailing P/E of -1.33 on trailing EPS of -0.222614679516382 USD.
What do analysts rate MREO?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 2.13 USD.